Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
Miyamoto M, Takano M, Kuwahara M, Soyama H, Kato K, Matuura H, Sakamoto T, Takasaki K, Aoyama T, Yoshikawa T, Furuya K. Miyamoto M, et al. Among authors: soyama h. Cancer Chemother Pharmacol. 2018 Jan;81(1):111-117. doi: 10.1007/s00280-017-3454-y. Epub 2017 Nov 9. Cancer Chemother Pharmacol. 2018. PMID: 29124328 Review.
Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.
Soyama H, Miyamoto M, Matsuura H, Iwahashi H, Kakimoto S, Ishibashi H, Sakamoto T, Hada T, Suminokura J, Takano M. Soyama H, et al. Cancer Chemother Pharmacol. 2020 May;85(5):941-947. doi: 10.1007/s00280-020-04070-8. Epub 2020 Apr 11. Cancer Chemother Pharmacol. 2020. PMID: 32279102
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?
Aoyama T, Takano M, Miyamoto M, Yoshikawa T, Soyama H, Kato K, Ishibashi H, Iwahashi H, Nakatsuka M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Goto T, Sasa H, Nagaoka I, Tsuda H, Furuya K. Aoyama T, et al. Among authors: soyama h. Cancer Chemother Pharmacol. 2017 Jul;80(1):65-69. doi: 10.1007/s00280-017-3332-7. Epub 2017 May 10. Cancer Chemother Pharmacol. 2017. PMID: 28493032
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.
Yoshikawa T, Takano M, Miyamoto M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Aoyama T, Soyama H, Goto T, Hirata J, Suzuki A, Sasa H, Nagaoka I, Tsuda H, Furuya K. Yoshikawa T, et al. Among authors: soyama h. Cancer Chemother Pharmacol. 2017 Sep;80(3):555-561. doi: 10.1007/s00280-017-3395-5. Epub 2017 Jul 19. Cancer Chemother Pharmacol. 2017. PMID: 28726081
[The impact of systematic lymphadenectomy for early-stage ovarian carcinomas].
Miyamoto M, Takano M, Goto T, Shibutani T, Matsuura H, Soyama H, Akimoto T, Asai K, Kawashima A, Watanabe A, Kato M, Yoshikawa T, Sasaki N, Hirata J, Sasa H, Furuya K. Miyamoto M, et al. Among authors: soyama h. Gan To Kagaku Ryoho. 2011 Nov;38(11):1837-40. Gan To Kagaku Ryoho. 2011. PMID: 22083192 Japanese.
60 results